Muzaffer Keklık

601 total citations
63 papers, 392 citations indexed

About

Muzaffer Keklık is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Muzaffer Keklık has authored 63 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 19 papers in Genetics and 12 papers in Oncology. Recurrent topics in Muzaffer Keklık's work include Hematopoietic Stem Cell Transplantation (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Blood donation and transfusion practices (6 papers). Muzaffer Keklık is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Blood donation and transfusion practices (6 papers). Muzaffer Keklık collaborates with scholars based in Türkiye, United States and Kazakhstan. Muzaffer Keklık's co-authors include Ali Ünal, Leylagül Kaynar, Mustafa Çetın, Serdar Şıvgın, Bülent Eser, Çiğdem Pala, Gökmen Zararsız, Serdal Korkmaz, Fatih Kurnaz and Mehmet Birhan Yılmaz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bone Marrow Transplantation and Annals of Hematology.

In The Last Decade

Muzaffer Keklık

54 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muzaffer Keklık Türkiye 13 168 107 80 71 43 63 392
Ìhsan Karadoǧan Türkiye 10 88 0.5× 36 0.3× 53 0.7× 24 0.3× 29 0.7× 26 250
Charles Knupp United States 12 241 1.4× 152 1.4× 30 0.4× 19 0.3× 19 0.4× 28 414
Emel Gürkan Türkiye 12 147 0.9× 117 1.1× 18 0.2× 39 0.5× 6 0.1× 32 267
Sofiane Tariket France 10 170 1.0× 24 0.2× 36 0.5× 88 1.2× 8 0.2× 16 425
Caroline R. Alquist United States 5 75 0.4× 42 0.4× 13 0.2× 64 0.9× 38 0.9× 16 250
Muhammad Saboor Saudi Arabia 11 148 0.9× 80 0.7× 29 0.4× 22 0.3× 12 0.3× 51 355
Richard Lemal France 11 108 0.6× 115 1.1× 139 1.7× 152 2.1× 43 1.0× 81 512
Melanie Tokessy Canada 10 181 1.1× 49 0.5× 9 0.1× 69 1.0× 15 0.3× 21 301
Jean‐Claude Osselaer Belgium 9 200 1.2× 43 0.4× 73 0.9× 41 0.6× 4 0.1× 18 471
Brynjar Viðarsson Iceland 9 142 0.8× 55 0.5× 37 0.5× 27 0.4× 31 0.7× 21 286

Countries citing papers authored by Muzaffer Keklık

Since Specialization
Citations

This map shows the geographic impact of Muzaffer Keklık's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muzaffer Keklık with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muzaffer Keklık more than expected).

Fields of papers citing papers by Muzaffer Keklık

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muzaffer Keklık. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muzaffer Keklık. The network helps show where Muzaffer Keklık may publish in the future.

Co-authorship network of co-authors of Muzaffer Keklık

This figure shows the co-authorship network connecting the top 25 collaborators of Muzaffer Keklık. A scholar is included among the top collaborators of Muzaffer Keklık based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muzaffer Keklık. Muzaffer Keklık is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ünal, Ali, et al.. (2024). AUTOLOGOUS STEM CELL TRANSPLANTATION EXPERIENCE IN B-ALL DEVELOPING DURING MAINTENANCE LENALIDOMIDE TREATMENT:CASE REPORT. Hematology Transfusion and Cell Therapy. 46. 8–9. 1 indexed citations
2.
Keklık, Muzaffer, et al.. (2024). CLL-232 Chronic Lymphocytic Leukemia: Immune Dysregulation and Management: A Case Report. Clinical Lymphoma Myeloma & Leukemia. 24. S348–S348.
3.
Keklık, Muzaffer, et al.. (2024). FLUDARABINE-INDUCED BRADYCARDIA IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. Hematology Transfusion and Cell Therapy. 46. 6–6. 1 indexed citations
4.
Keklık, Muzaffer, et al.. (2024). EFFICACY OF GLOFITAMAB IN PRIMARY REFRACTORY LYMPHOMA: A CASE REPORT. Hematology Transfusion and Cell Therapy. 46. S57–S57.
5.
Keklık, Muzaffer, et al.. (2024). CT-249 Treatment of Hematopoietic Stem Cell Transplant-Associated Microangiopathy with Eculizumab. Clinical Lymphoma Myeloma & Leukemia. 24. S594–S594.
6.
Keklık, Muzaffer, et al.. (2024). Uric Acid Levels Might be A Prognostic Indicator For Survival in Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation. Single-Center Experience. Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi.
7.
Keklık, Muzaffer, et al.. (2023). Coronavirus Anxiety Level and COVID-19 Vaccine Attitude Among Patients With Hematological Malignancies. Cureus. 15(5). e38618–e38618. 1 indexed citations
8.
9.
Keklık, Muzaffer, et al.. (2020). Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma. Transfusion and Apheresis Science. 59(5). 102844–102844. 2 indexed citations
10.
Karaman, Hati̇ce, et al.. (2019). Do PD-1 and PD-L2 expressions have prognostic impact in hematologic malignancies?. DergiPark (Istanbul University). 2 indexed citations
11.
12.
Keklık, Muzaffer, et al.. (2016). An Evaluation of the Impact of Therapeutic Phlebotomy on Systemic Endothelial Functions in Polycythemic Patients with the Flow-Mediated Vasodilatation Method. Indian Journal of Hematology and Blood Transfusion. 33(3). 441–442. 2 indexed citations
13.
14.
Taşdemir, Şener, et al.. (2015). Does the Level of WT1 Expression Predict the Outcome in Philadelphia-Negative Myeloproliferative Neoplasms?. Genetic Testing and Molecular Biomarkers. 19(4). 222–224. 1 indexed citations
15.
Keklık, Muzaffer, Serdar Şıvgın, Kemal Denız, et al.. (2013). Coincidence of three solid tumors in a patient with multiple myeloma. Chinese Medical Journal. 126(6). 1186–1187. 2 indexed citations
16.
Baldane, Süleyman, Muzaffer Keklık, Leylagül Kaynar, et al.. (2013). The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem?. Transplantation Proceedings. 45(9). 3371–3374. 11 indexed citations
17.
Keklık, Muzaffer, Serdar Şıvgın, Çiğdem Pala, et al.. (2013). The management of hyperleukocytosis in an adult patient with acute lymphoblastic leukemia and ataxia-telangiectasia. Transfusion and Apheresis Science. 48(3). 293–295. 4 indexed citations
18.
Pala, Çiğdem, Muzaffer Keklık, Serdar Şıvgın, et al.. (2013). A rare but severe complication of filgrastim in a healthy donor: Splenic rupture. Transfusion and Apheresis Science. 50(1). 53–55. 14 indexed citations
19.
20.
Kaya, Emın, Muzaffer Keklık, Mehmet Şencan, et al.. (2013). Therapeutic plasma exchange in patients with neurological diseases: Multicenter retrospective analysis. Transfusion and Apheresis Science. 48(3). 349–352. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ìhsan Karadoǧan Breakdown of academic impact, for papers by Charles Knupp Breakdown of academic impact, for papers by Emel Gürkan Breakdown of academic impact, for papers by Sofiane Tariket Breakdown of academic impact, for papers by Caroline R. Alquist Breakdown of academic impact, for papers by Muhammad Saboor Breakdown of academic impact, for papers by Richard Lemal Breakdown of academic impact, for papers by Melanie Tokessy Breakdown of academic impact, for papers by Jean‐Claude Osselaer Breakdown of academic impact, for papers by Brynjar Viðarsson
Rankless by CCL
2026